Ubiquitin Carboxyl-Terminal Hydrolase CYLD
CYLD is a deubiquitination enzyme that is responsible for cleaving polyubiquitin chains from multiple target proteins and for regulating downstream signaling pathways. Originally, CYLD gene was discovered through positional cloning from chromosome 16q. The germ-line mutations in CYLD gene were identified in patients suffering from familial cylindromatosis, which is a skin cancer disease (Biggs et al. 1995; Bignell et al. 2000). Both copies of the gene must be inactivated to cause cylindromatosis, which is usually an inherited mutation in one copy and loss of the second copy during postnatal life. CYLD consists of 956 amino acids, 20 exons, and it is scattered over 56 kb of genomic...
- Strobel P, Zettl A, Ren Z, Starostik P, Riedmiller H, Storkel S, et al. Spiradenocylindroma of the kidney: clinical and genetic findings suggesting a role of somatic mutation of the CYLD1 gene in the oncogenesis of an unusual renal neoplasm. Am J Surg Pathol. 2002;26(1):119–24.PubMedCrossRefGoogle Scholar
- Zhong S, Fields CR, Su N, Pan YX, Robertson KD. Pharmacologic inhibition of epigenetic modi. cations, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene. 2007;26(18):2621–34.PubMedPubMedCentralCrossRefGoogle Scholar